Literature DB >> 23041578

Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery.

Florian Rader1, Akshat C Pujara, Gregory Pattakos, Jeevanantham Rajeswaran, Liang Li, Laurie Castel, Mina K Chung, A Marc Gillinov, Otto Costantini, David R Van Wagoner, Eugene H Blackstone.   

Abstract

BACKGROUND: Postoperative atrial fibrillation (POAF) is common and associated with poor outcomes. Perioperative ischemia can alter arrhythmic substrate.
OBJECTIVE: To demonstrate an association between perioperative measurements of heart-type fatty acid binding protein (HT-FABP), a sensitive marker of ischemic myocardial injury.
METHODS: Blood samples from 63 inpatients undergoing coronary artery bypass surgery, valve surgery, or both were obtained before and up to 4 days after surgery. Continuous telemetry monitoring was used to detect POAF. Fifty-nine patients had at least 3 HT-FABP measurements. The relationship of enzyme-linked immunosorbent assay-measured HT-FABP with POAF was assessed by using joint logistic regression adjusted for age and surgery type.
RESULTS: Thirty-five patients (55%) developed POAF; these were, on average, older (69.3±10 years vs 60±11 years; P = .0019), with a higher prevalence of heart failure (43% vs 17%; P = .034), chronic obstructive lung disease (26% vs 4%; P = .017), preoperative calcium channel blocker use (29% vs 7%; P = .031), and more likely to undergo combined surgery (21% vs 11%, P = .049). The joint age- and coronary artery bypass surgery-adjusted model revealed that postoperative but not preoperative HT-FABP levels predicted POAF (coefficient 1.9±0.87; P = .03). Longer bypass time, prior infarction, and worse renal function were all associated with higher postoperative HT-FABP.
CONCLUSIONS: A greater rise of HT-FABP is associated with atrial fibrillation after cardiac surgery, suggesting that ischemic myocardial damage is a contributing underlying mechanism. Interventions that decrease perioperative ischemic injury may also decrease the occurrence of POAF.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041578      PMCID: PMC3687792          DOI: 10.1016/j.hrthm.2012.10.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  25 in total

Review 1.  Breaking down barriers: helpful breakthrough statistical methods you need to understand better.

Authors:  E H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2001-09       Impact factor: 5.209

2.  Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma.

Authors:  B N Singh; R M Whitlock; R H Comber; F H Williams; E A Harris
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

3.  Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?

Authors:  S H Taylor; B Silke; P S Lee
Journal:  N Engl J Med       Date:  1982-03-18       Impact factor: 91.245

4.  Early enzyme release from myocardial cells is not due to irreversible cell damage.

Authors:  H M Piper; P Schwartz; R Spahr; J F Hütter; P G Spieckermann
Journal:  J Mol Cell Cardiol       Date:  1984-04       Impact factor: 5.000

5.  Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized study.

Authors:  R Ascione; M Caputo; G Calori; C T Lloyd; M J Underwood; G D Angelini
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

6.  A multicenter risk index for atrial fibrillation after cardiac surgery.

Authors:  Joseph P Mathew; Manuel L Fontes; Iulia C Tudor; James Ramsay; Peter Duke; C David Mazer; Paul G Barash; Ping H Hsu; Dennis T Mangano
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

7.  The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement.

Authors:  E Rechavia; B Strasberg; A Mager; N Zafrir; J Kusniec; A Sagie; S Sclarovsky
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

8.  The prognostic significance of exercise-induced atrial arrhythmias.

Authors:  T Jared Bunch; Krishnaswamy Chandrasekaran; Bernard J Gersh; Stephen C Hammill; David O Hodge; Akbar H Khan; Douglas L Packer; Patricia A Pellikka
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

9.  Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone.

Authors:  Donna M Gallik; Igor Singer; Marc D Meissner; Janos Molnar; John C Somberg
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778

10.  Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.

Authors:  J F Glatz; A H Kleine; F A van Nieuwenhoven; W T Hermens; M P van Dieijen-Visser; G J van der Vusse
Journal:  Br Heart J       Date:  1994-02
View more
  2 in total

Review 1.  Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a Biomarker in Heart Failure: What Do We Know So Far?

Authors:  Richard Rezar; Peter Jirak; Martha Gschwandtner; Rupert Derler; Thomas K Felder; Michael Haslinger; Kristen Kopp; Clemens Seelmaier; Christina Granitz; Uta C Hoppe; Michael Lichtenauer
Journal:  J Clin Med       Date:  2020-01-07       Impact factor: 4.241

2.  Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies.

Authors:  Ruben R De With; Vicente Artola Arita; Bao-Oanh Nguyen; Dominik Linz; Hugo Ten Cate; Henri Spronk; Ulrich Schotten; Anton Jan van Zonneveld; Ömer Erküner; M Agustina Bayón; Anders S Schmidt; Justin G L M Luermans; Harry J G M Crijns; Isabelle C Van Gelder; Michiel Rienstra
Journal:  Europace       Date:  2022-02-02       Impact factor: 5.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.